Structural and dynamical properties of different protonated states of mutant HIV-1 protease complexed with the saquinavir inhibitor studied by molecular dynamics simulations

被引:7
作者
Aruksakunwong, Ornjira
Wittayanarakul, Kitiyaporn
Sompornpisut, Pornthep
Sanghiran, Vannajan
Parasuk, Vudthichai
Hannongbua, Supot [1 ]
机构
[1] Chulalongkorn Univ, Fac Sci, Dept Chem, Bangkok 10330, Thailand
[2] Chiang Mai Univ, Fac Sci, Dept Chem, Chiang Mai 50200, Thailand
关键词
HIV-1; protease; molecular dynamics simulations; mutation; protonation state; saquinavir;
D O I
10.1016/j.jmgm.2006.01.004
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To understand the basis of drug resistance, particularly of the HIV-1 PR, three molecular dynamics (MD) simulations of HIV-1 PR mutant species, G48V, complexed with saquinavir (SQV) in explicit aqueous solution with three protonation states, diprotonation on Asp25 and Asp25' (Di-pro) and monoprotonation on each Asp residue (Mono-25 and Mono-25'). For all three states, H-bonds between saquinavir and HIV-1 PR were formed only in the two regions, flap and active site. It was found that conformation of P2 subsite of SQV in the Mono-25 state differs substantially from the other two states. The rotation about 177 degrees' from the optimal structure of the wild type was observed, the hydrogen bond between P2 and the flap residue (Va148) was broken and indirect hydrogen bonds with the three residues (Asp29, Gly27, and Asp30) were found instead. In terms of complexation energies, interaction energy of -37.3 kcal/mol for the Mono-25 state is significantly lower than those of -30.7 and - 10.7 kcal/mol for the Mono-25' and Di-pro states, respectively. It was found also that protonation at the Asp25 leads to a better arrangement in the catalytic dyad, i.e., the Asp25-Asp25' interaction energy of -8.8 kcal/mol of the Mono-25 is significantly lower than that of -2.6 kcal/mol for the Mono-25' state. The above data suggest us to conclude that interaction in the catalytic area should be used as criteria to enhance capability in drug designing and drug screening instead of using the total inhibitor/enzyme interaction. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:324 / 332
页数:9
相关论文
共 24 条
[1]   A WELL-BEHAVED ELECTROSTATIC POTENTIAL BASED METHOD USING CHARGE RESTRAINTS FOR DERIVING ATOMIC CHARGES - THE RESP MODEL [J].
BAYLY, CI ;
CIEPLAK, P ;
CORNELL, WD ;
KOLLMAN, PA .
JOURNAL OF PHYSICAL CHEMISTRY, 1993, 97 (40) :10269-10280
[2]   MOLECULAR-DYNAMICS WITH COUPLING TO AN EXTERNAL BATH [J].
BERENDSEN, HJC ;
POSTMA, JPM ;
VANGUNSTEREN, WF ;
DINOLA, A ;
HAAK, JR .
JOURNAL OF CHEMICAL PHYSICS, 1984, 81 (08) :3684-3690
[3]  
Case D.A., 2002, AMBER 7
[4]   Kinetic properties of saquinavir-resistant mutants of human immunodeficiency virus type 1 protease and their implications in drug resistance in vivo [J].
Ermolieff, J ;
Lin, XL ;
Tang, J .
BIOCHEMISTRY, 1997, 36 (40) :12364-12370
[5]  
FRISCH MJ, 1998, GAUSSIAN 98 PROGRAM
[6]   Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: Insights into the mechanisms of drug resistance [J].
Hong, L ;
Zhang, XJC ;
Hartsuck, JA ;
Tang, J .
PROTEIN SCIENCE, 2000, 9 (10) :1898-1904
[7]   COMPARISON OF SIMPLE POTENTIAL FUNCTIONS FOR SIMULATING LIQUID WATER [J].
JORGENSEN, WL ;
CHANDRASEKHAR, J ;
MADURA, JD ;
IMPEY, RW ;
KLEIN, ML .
JOURNAL OF CHEMICAL PHYSICS, 1983, 79 (02) :926-935
[8]   Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage therapy [J].
Kantor, R ;
Fessel, WJ ;
Zolopa, AR ;
Israelski, D ;
Shulman, N ;
Montoya, JG ;
Harbour, M ;
Schapiro, JM ;
Shafer, RW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) :1086-1092
[9]   NOVEL BINDING MODE OF HIGHLY POTENT HIV-PROTEINASE INHIBITORS INCORPORATING THE (R)-HYDROXYETHYLAMINE ISOSTERE [J].
KROHN, A ;
REDSHAW, S ;
RITCHIE, JC ;
GRAVES, BJ ;
HATADA, MH .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (11) :3340-3342
[10]   Structural implications of drug-resistant mutants of HIV-1 protease: High-resolution crystal structures of the mutant protease/substrate analogue complexes [J].
Mahalingam, B ;
Louis, JM ;
Hung, J ;
Harrison, RW ;
Weber, IT .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 2001, 43 (04) :455-464